First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Adjuvants, Immunologic

Back to Details
This is a "connection" page, showing publications Karl-Erik Andersson has written about Adjuvants, Immunologic.
Karl-Erik Andersson
Connection Strength
0.086
Adjuvants, Immunologic
  1. Huijbers EJ, Femel J, Andersson K, Björkelund H, Hellman L, Olsson AK. The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B--a prerequisite for clinical development. Vaccine. 2012 Jan 05; 30(2):225-30.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.